Sensus Healthcare, Inc.
SRTS · NASDAQ
9/30/2025 | 6/30/2025 | 3/31/2025 | 12/31/2024 | |
|---|---|---|---|---|
| Valuation | ||||
| PEG Ratio | 1.51 | 0.31 | 0.03 | 0.67 |
| FCF Yield | 0.00% | 3.99% | -3.48% | -0.47% |
| EV / EBITDA | 43.97 | -31.25 | -23.49 | 49.24 |
| Quality | ||||
| ROIC | 8.95% | -2.17% | -5.14% | 2.42% |
| Gross Margin | 39.41% | 39.69% | 52.18% | 54.39% |
| Cash Conversion Ratio | – | -3.01 | 1.04 | -0.53 |
| Growth | ||||
| Revenue 3-Year CAGR | 12.60% | 7.72% | 1.64% | -2.08% |
| Free Cash Flow Growth | -100.00% | 215.13% | -406.42% | -114.66% |
| Safety | ||||
| Net Debt / EBITDA | -38.46 | 12.08 | 7.36 | -11.53 |
| Interest Coverage | 0.00 | 0.00 | 0.00 | 0.00 |
| Efficiency | ||||
| Inventory Turnover | 0.29 | 0.36 | 0.40 | 0.44 |
| Cash Conversion Cycle | 311.12 | 298.90 | 291.07 | 266.27 |